PRINCETON, N.J., Sept. 24 /PRNewswire-FirstCall/ -- Novo Nordisk, a world leader in diabetes care, announced that effective today, the company is listed in the Dow Jones Sustainability World Index (DJSI World) as best-in-class in the healthcare industry -- one of 18 global supersectors analyzed.
The latest global analysis of corporate sustainability leadership was based on a thorough analysis of companies' economic, environmental and social performance, assessing issues including corporate governance, risk management, branding, climate change, supply chain standards and labor practices.
The report concludes "Novo Nordisk is the leading company in terms of sustainability in the pharmaceutical industry. Sustainability is an integral part of its corporate strategy and business organization."
The report continues, "Novo Nordisk is particularly strong in the social dimension where it achieved the industry top ratings in human capital development, corporate citizenship/philanthropy, and social reporting." The company's responsible sourcing, environmental management, bioethics and climate strategy also achieve high scores.
"This honor provides us further encouragement for operating our business according to our Triple Bottom Line philosophy -- a company that can be economically vital, as well as socially and environmentally responsible," said Martin Sorters, president, Novo Nordisk in the United States.
"Our passion for changing diabetes is supported by an understanding that sustainability in business is not just possible but necessary. By putting the patient at the center of all we do -- from providing the best therapies to patients and advocating our employees' volunteerism with patient groups and at diabetes camps to our environmental stewardship through water conservation efforts and our climate change strategy -- we strive to be successful and responsible."
The indexes, which currently comprise USD$5.6 billion assets under
|SOURCE Novo Nordisk|
Copyright©2007 PR Newswire.
All rights reserved